{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:18:05Z","timestamp":1777565885420,"version":"3.51.4"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002251","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T17:04:45Z","timestamp":1320339885000},"page":"e1002251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":79,"title":["High Degree of Heterogeneity in Alzheimer's Disease Progression Patterns"],"prefix":"10.1371","volume":"7","author":[{"given":"Natalia L.","family":"Komarova","sequence":"first","affiliation":[]},{"given":"Craig J.","family":"Thalhauser","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"ref1","first-page":"57","article-title":"The significance of clinically defined subgroups of Alzheimer's disease.","volume":"Transm","author":"HC Chui","year":"1987","journal-title":"J Neural"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jnnp.55.10.956","article-title":"Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.","volume":"55","author":"UM Mann","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.51.1.149","article-title":"Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.","volume":"51","author":"S Craft","year":"1998","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archneur.1995.00540330100021","article-title":"Rate of progression of Alzheimer's disease is associated with genetic risk.","volume":"52","author":"LA Farrer","year":"1995","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.56.11.1595","article-title":"Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.","volume":"56","author":"GM Murphy Jr","year":"2001","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.","volume":"62","author":"CR Jack Jr","year":"2004","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1474-4422(06)70550-6","article-title":"Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.","volume":"5","author":"BH Ridha","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000311446.61861.e3","article-title":"Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.","volume":"70","author":"JD Sluimer","year":"2008","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiol.2511080924","article-title":"Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.","volume":"251","author":"LK McEvoy","year":"2009","journal-title":"Radiology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.","volume":"131","author":"SM Nestor","year":"2008","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000279520.59792.fe","article-title":"Vascular factors predict rate of progression in Alzheimer disease.","volume":"69","author":"MM Mielke","year":"2007","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.6026\/97320630001363","article-title":"Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression.","volume":"1","author":"P Prolo","year":"2007","journal-title":"Bioinformation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1212\/WNL.43.12.2457","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.","volume":"43","author":"JC Morris","year":"1993","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/WNL.59.7.1034","article-title":"Rates of progression in mild cognitive impairment and early Alzheimer's disease.","volume":"59","author":"M Storandt","year":"2002","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000017239","article-title":"Predictors of cognitive decline in the early stage of probable Alzheimer's disease.","volume":"11","author":"C Marra","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0891988706286505","article-title":"Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.","volume":"19","author":"D Bhargava","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(89)90857-X","article-title":"Rapidly progressive Alzheimer's disease.","volume":"2","author":"UM Mann","year":"1989","journal-title":"Lancet"},{"key":"ref18","first-page":"203","article-title":"Subgroups in Alzheimer's disease: fact or fiction?","volume":"15","author":"E Mohr","year":"1990","journal-title":"Psychiatr J Univ Ott"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/gps.1168","article-title":"A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.","volume":"19","author":"GH Suh","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia.","volume":"139","author":"B Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"ref21","first-page":"653","article-title":"Functional assessment staging (FAST).","volume":"24","author":"B Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","article-title":"Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.","volume":"4","author":"SG Sclan","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"ref23","first-page":"629","article-title":"Brief Cognitive Rating Scale (BCRS).","volume":"24","author":"B Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/156720510791162340","article-title":"Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.","volume":"7","author":"MN Sabbagh","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1041610297004869","article-title":"The GDS\/FAST staging system.","volume":"9","author":"S Auer","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S1041610296002657","article-title":"Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study.","volume":"8","author":"B Reisberg","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"ref27","first-page":"30","article-title":"Dementia: a systematic approach to identifying reversible causes.","volume":"41","author":"B Reisberg","year":"1986","journal-title":"Geriatrics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0895-4356(92)90201-W","article-title":"Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?","volume":"45","author":"K Ritchie","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.35.4.453","article-title":"Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.","volume":"35","author":"R Mayeux","year":"1985","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/0003-4819-109-4-298","article-title":"NIH conference. Alzheimer disease: clinical and biological heterogeneity.","volume":"109","author":"RP Friedland","year":"1988","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-1781(85)90020-4","article-title":"Aphasia, family history, and the longitudinal course of senile dementia of the Alzheimer type.","volume":"14","author":"JW Knesevich","year":"1985","journal-title":"Psychiatry Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt25","article-title":"Predicting progression of Alzheimer's disease.","volume":"2","author":"RS Doody","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"ref33","article-title":"Alzheimer's disease: rapid and slow progression.","author":"CJ Thalhauser","year":"2011"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/01.wnl.0000345014.48839.71","article-title":"CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.","volume":"72","author":"AE van der Vlies","year":"2009","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e3181bd8271","article-title":"CSF biomarkers predict rate of cognitive decline in Alzheimer disease.","volume":"73","author":"MI Kester","year":"2009","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000322202","article-title":"EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease.","volume":"31","author":"LL Smits","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1001101","DOI":"10.1371\/journal.pgen.1001101","article-title":"SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.","volume":"6","author":"C Cruchaga","year":"2010","journal-title":"PLoS Genet"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195152968.001.0001","article-title":"Applied Longitudinal data analysis: modeling change and event occurrence.","author":"J Singer","year":"2003"},{"key":"ref39","article-title":"Longitudinal data analysis.","year":"2009"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1191\/147108201128195","article-title":"A review on linear mixed models for lon- gitudinal data, possibly subject to dropout.","volume":"1","author":"G Molenberghs","year":"2001","journal-title":"Stat Modelling"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival following a diagnosis of Alzheimer disease.","volume":"59","author":"R Brookmeyer","year":"2002","journal-title":"Arch Neurol"},{"key":"ref42","first-page":"290","article-title":"The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc Series B Stat Methodol","volume":"38","author":"BW Turnbull","year":"1976"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2532030","article-title":"Analysis of doubly-censored survival data, with application to AIDS.","volume":"45","author":"V De Gruttola","year":"1989","journal-title":"Biometrics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2307\/2533210","article-title":"Estimation of the infection time and latency distribution of AIDS with doubly censored data.","volume":"50","author":"G Gomez","year":"1994","journal-title":"Biometrics"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T16:53:27Z","timestamp":1540313607000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002251"}},"subtitle":[],"editor":[{"given":"Lawrence E.","family":"Hunter","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002251","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}